Mark A. Seefeld

1.6k total citations
20 papers, 916 citations indexed

About

Mark A. Seefeld is a scholar working on Organic Chemistry, Molecular Biology and Microbiology. According to data from OpenAlex, Mark A. Seefeld has authored 20 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Organic Chemistry, 10 papers in Molecular Biology and 4 papers in Microbiology. Recurrent topics in Mark A. Seefeld's work include Asymmetric Synthesis and Catalysis (7 papers), Chemical Synthesis and Analysis (4 papers) and Antimicrobial agents and applications (4 papers). Mark A. Seefeld is often cited by papers focused on Asymmetric Synthesis and Catalysis (7 papers), Chemical Synthesis and Analysis (4 papers) and Antimicrobial agents and applications (4 papers). Mark A. Seefeld collaborates with scholars based in United States and United Kingdom. Mark A. Seefeld's co-authors include Anthony G. M. Barrett, Bruce A. Lefker, A. I. MEYERS, James F. Blake, Terrance Moore, Kenneth A. Newlander, Stephen Rittenhouse, Walter E. DeWolf, David Payne and Dirk A. Heerding and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Mark A. Seefeld

20 papers receiving 863 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Seefeld United States 16 563 425 121 98 78 20 916
Chunhua Qiao China 20 507 0.9× 590 1.4× 16 0.1× 40 0.4× 27 0.3× 56 1.3k
Renee A. Bouley United States 11 328 0.6× 317 0.7× 30 0.2× 141 1.4× 13 0.2× 30 752
Terkel Hansen Norway 18 367 0.7× 574 1.4× 155 1.3× 20 0.2× 31 0.4× 44 1.2k
Rajendra Tangallapally United States 13 328 0.6× 340 0.8× 17 0.1× 35 0.4× 11 0.1× 24 622
Joshua G. Pierce United States 20 714 1.3× 440 1.0× 107 0.9× 79 0.8× 65 0.8× 63 1.1k
Yong-Kang Zhang China 16 388 0.7× 353 0.8× 15 0.1× 17 0.2× 42 0.5× 27 924
Tetsuo Yamasaki Japan 11 219 0.4× 332 0.8× 22 0.2× 292 3.0× 13 0.2× 51 799
Mohammad A. Alam United States 20 623 1.1× 348 0.8× 45 0.4× 36 0.4× 29 0.4× 51 839
Ravindranadh V. Somu United States 8 227 0.4× 459 1.1× 27 0.2× 62 0.6× 8 0.1× 8 707
Mark S. Plummer United States 12 178 0.3× 317 0.7× 17 0.1× 39 0.4× 12 0.2× 20 530

Countries citing papers authored by Mark A. Seefeld

Since Specialization
Citations

This map shows the geographic impact of Mark A. Seefeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Seefeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Seefeld more than expected).

Fields of papers citing papers by Mark A. Seefeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Seefeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Seefeld. The network helps show where Mark A. Seefeld may publish in the future.

Co-authorship network of co-authors of Mark A. Seefeld

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Seefeld. A scholar is included among the top collaborators of Mark A. Seefeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Seefeld. Mark A. Seefeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wooddell, Christine I., Rong Zhu, Qili Chu, et al.. (2018). Development of subcutaneously administered RNAi therapeutic ARO-HBV for chronic hepatitis B virus infection. Journal of Hepatology. 68. S18–S19. 13 indexed citations
2.
Ellis, James L., Mark A. Seefeld, William H. Miller, et al.. (2017). LB985 GSK2967901A, a novel small molecule SIRT1 activator for the topical treatment of psoriasis. Journal of Investigative Dermatology. 137(10). B10–B10. 2 indexed citations
3.
Dumble, Melissa, Ming‐Chih Crouthamel, Shuyun Zhang, et al.. (2014). Discovery of Novel AKT Inhibitors with Enhanced Anti-Tumor Effects in Combination with the MEK Inhibitor. PLoS ONE. 9(6). e100880–e100880. 116 indexed citations
4.
Wang, Jizhou, Mark A. Seefeld, & Juan I. Luengo. (2011). Unusual ligand-dependent chemoselective Suzuki–Miyaura cross-coupling reactions of 3-bromo-4-trifloyl-thiophenes. Tetrahedron Letters. 52(48). 6346–6348. 14 indexed citations
5.
Rouse, Meagan B., Mark A. Seefeld, Jack D. Leber, et al.. (2009). Aminofurazans as potent inhibitors of AKT kinase. Bioorganic & Medicinal Chemistry Letters. 19(5). 1508–1511. 33 indexed citations
6.
Seefeld, Mark A., Meagan B. Rouse, Jizhou Wang, et al.. (2009). Discovery of 5-pyrrolopyridinyl-2-thiophenecarboxamides as potent AKT kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(8). 2244–2248. 21 indexed citations
7.
Li, Hu, Jianzhong Huang, Xin-he Jiang, et al.. (2003). Technical Note: The Effect of Triton Concentration on the Activity of Undecaprenyl Pyrophosphate Synthase Inhibitors. SLAS DISCOVERY. 8(6). 712–715. 19 indexed citations
8.
Seefeld, Mark A., William H. Miller, Kenneth A. Newlander, et al.. (2003). Indole Naphthyridinones as Inhibitors of Bacterial Enoyl-ACP Reductases FabI and FabK. Journal of Medicinal Chemistry. 46(9). 1627–1635. 133 indexed citations
9.
Choudhry, Anthony E., Cynthia Kinsland, Tadhg P. Begley, et al.. (2003). Inhibitors of Pantothenate Kinase: Novel Antibiotics for Staphylococcal Infections. Antimicrobial Agents and Chemotherapy. 47(6). 2051–2055. 77 indexed citations
10.
Fan, Frank, Nicola G. Wallis, Terrance Moore, et al.. (2002). Defining and Combating the Mechanisms of Triclosan Resistance in Clinical Isolates ofStaphylococcus aureus. Antimicrobial Agents and Chemotherapy. 46(11). 3343–3347. 84 indexed citations
11.
Miller, William H., Mark A. Seefeld, Kenneth A. Newlander, et al.. (2002). Discovery of Aminopyridine-Based Inhibitors of Bacterial Enoyl-ACP Reductase (FabI). Journal of Medicinal Chemistry. 45(15). 3246–3256. 90 indexed citations
12.
Seefeld, Mark A., William H. Miller, Kenneth A. Newlander, et al.. (2001). Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agents. Bioorganic & Medicinal Chemistry Letters. 11(17). 2241–2244. 52 indexed citations
13.
MEYERS, A. I., Mark A. Seefeld, Bruce A. Lefker, James F. Blake, & Paul G. Williard. (1998). ChemInform Abstract: Stereoselective Alkylations in Rigid Systems. Effect of Remote Substituents on π‐Facial Additions to Lactam Enolates. Stereoselectronic and Steric Effects.. ChemInform. 29(49). 4 indexed citations
14.
MEYERS, A. I., Mark A. Seefeld, Bruce A. Lefker, James F. Blake, & Paul G. Williard. (1998). Stereoselective Alkylations in Rigid Systems. Effect of Remote Substituents on π-Facial Additions to Lactam Enolates. Stereoelectronic and Steric Effects. Journal of the American Chemical Society. 120(30). 7429–7438. 64 indexed citations
15.
MEYERS, A. I., Mark A. Seefeld, Bruce A. Lefker, & James F. Blake. (1997). Origin of Stereochemistry in Simple Pyrrolidinone Enolate Alkylations. Journal of the American Chemical Society. 119(19). 4565–4566. 44 indexed citations
16.
Barrett, Anthony G. M., Mark A. Seefeld, Andrew J. P. White, & David J. Williams. (1996). Convenient Asymmetric Syntheses of anti-β-Amino Alcohols. The Journal of Organic Chemistry. 61(8). 2677–2685. 45 indexed citations
17.
MEYERS, A. I., Mark A. Seefeld, & Bruce A. Lefker. (1996). Chiral Bicyclic Lactams. A New Study on Facial Alkylation. The Journal of Organic Chemistry. 61(17). 5712–5713. 24 indexed citations
18.
Barrett, Anthony G. M., Mark A. Seefeld, & David Williams. (1994). A convenient asymmetric synthesis of anti-β-amino alcohols: an X-ray crystallographic study of (4R)-2,2-dimethyl-4-[(2S)-(diphenylmethyleneamino)-(1S)-hydroxy-3-buten-1-yl]-1,3-dioxolane. Journal of the Chemical Society Chemical Communications. 1053–1054. 26 indexed citations
19.
Barrett, Anthony G. M. & Mark A. Seefeld. (1993). B-[E-3-(diphenylamino)allyl]diisopinocampheylborane: an excellent reagent for the stereoselective synthesis of anti-β-diphenylamino alcohols. Journal of the Chemical Society Chemical Communications. 339–341. 19 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chunhua Qiao Breakdown of academic impact, for papers by Renee A. Bouley Breakdown of academic impact, for papers by Terkel Hansen Breakdown of academic impact, for papers by Rajendra Tangallapally Breakdown of academic impact, for papers by Joshua G. Pierce Breakdown of academic impact, for papers by Yong-Kang Zhang Breakdown of academic impact, for papers by Tetsuo Yamasaki Breakdown of academic impact, for papers by Mohammad A. Alam Breakdown of academic impact, for papers by Ravindranadh V. Somu Breakdown of academic impact, for papers by Mark S. Plummer
Rankless by CCL
2026